Insider Stock Trading History of Lebuhn Robert


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Lebuhn Robert since year 2005. The trader's CIK number is 1007931. At the time of this reporting, Lebuhn Robert is the Director of Enzon Pharmaceuticals Inc . (stock ticker symbol ENZN). See this page for all insider trading activities at Enzon Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Lebuhn Robert since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-09-17 ENZN Enzon Pharmaceuticals Inc Sale 34,807 1.74 60,459
2013-09-19 ENZN Enzon Pharmaceuticals Inc Sale 21,119 1.69 35,627
2012-08-14 ENZN Enzon Pharmaceuticals Inc Sale 5,820 6.58 38,307
2012-08-10 ENZN Enzon Pharmaceuticals Inc Sale 1,933 6.58 12,719
2011-06-01 ENZN Enzon Pharmaceuticals Inc Sale 8,702 10.57 91,980
2011-02-22 ENZN Enzon Pharmaceuticals Inc Sale 10,000 10.88 108,820
2010-08-26 ENZN Enzon Pharmaceuticals Inc Sale 10,000 10.50 104,980
2010-07-02 ENZN Enzon Pharmaceuticals Inc Option Ex 3,173 .00 0
2009-07-02 ENZN Enzon Pharmaceuticals Inc Option Ex 3,173 .00 0
2009-07-03 ENZN Enzon Pharmaceuticals Inc Option Ex 1,106 .00 0
2008-07-01 ENZN Enzon Pharmaceuticals Inc Option Ex 1,255 .00 0
2008-07-02 ENZN Enzon Pharmaceuticals Inc Option Ex 3,172 .00 0
2008-07-03 ENZN Enzon Pharmaceuticals Inc Option Ex 1,105 .00 0
2007-07-01 ENZN Enzon Pharmaceuticals Inc Option Ex 1,255 .00 0
2007-07-03 ENZN Enzon Pharmaceuticals Inc Option Ex 1,105 .00 0
2007-01-02 ENZN Enzon Pharmaceuticals Inc Option Ex 40,000 2.94 117,480
2006-07-01 ENZN Enzon Pharmaceuticals Inc Option Ex 1,255 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lebuhn Robert (Director of Enzon Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.